Related Experiment Video
Updated: Jul 18, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.2K
Biomarkers in Atopic Dermatitis
Florence Libon1, Juliette Caron2, Arjen F Nikkels3
1Unit of Dermato-Allergology, Department of Dermatology and Venerology, University Hospital of Liège-Liège, CHU of Sart Tilman, University of Liège, 4000, Liège, Belgium.
Dermatology and Therapy
|June 14, 2024
Summary
Biomarkers are crucial for diagnosing and managing atopic dermatitis (AD). Further research is needed to integrate these biomarkers into personalized treatment strategies for AD patients.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin disease.
- Its development involves genetic, environmental, immunological factors, and epidermal barrier dysfunction.
- Biomarkers are essential for AD diagnosis, severity assessment, and treatment monitoring.
Purpose of the Study:
- To review current biomarkers for atopic dermatitis (AD).
- To explore the relationship between biomarkers and different AD phenotypes and endotypes.
- To highlight the need for further research in AD biomarker development for personalized medicine.
Main Methods:
- Literature review of existing studies on AD biomarkers.
- Categorization of biomarkers into diagnostic, prognostic, severity, and stratification types.
- Analysis of biomarker relevance across diverse AD phenotypes and endotypes.
Main Results:
- Biomarkers show potential for personalized treatment approaches in AD.
- Current therapeutic advancements include interleukin (IL) antagonists and Janus kinase (JAK) inhibitors.
- Significant research gaps remain in establishing the role of biomarkers in AD diagnosis and prognosis.
Conclusions:
- Biomarkers are key to advancing personalized medical care for atopic dermatitis (AD).
- Further investigation is required to fully elucidate the diagnostic and prognostic value of biomarkers in AD.
- Integrating biomarkers will enhance the scientific basis for tailored AD treatments.
Related Concept Videos
01:27The Skin Microbiota
The human skin serves as a complex ecosystem inhabited by a diverse community of microorganisms, including bacteria, fungi, and viruses. This microbiome plays a critical role in maintaining skin health and defending against pathogenic invaders. The composition of microbial communities varies significantly across different regions of the body, influenced primarily by the local levels of moisture and sebum.Regional Variation in Skin MicrobiotaCutibacterium acnes predominantly colonizes sebaceous...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.